<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>59(2)</volume><submitter>Gupta N</submitter><pubmed_abstract>&lt;h4>Objective&lt;/h4>To differentiate severe/critical coronavirus disease 2019 (COVID-19) infection from multisystem inflammatory syndrome in children (MIS-C).&lt;h4>Methods&lt;/h4>Single-center chart review comparing characteristics of children with MIS-C and 'severe/critical' COVID-19 infection. Multivariate logistic regression was performed to create predictive models for predicting MIS-C.&lt;h4>Results&lt;/h4>Of 68 patients, 28 (41.2%) had MIS-C while 40 (58.8%) had severe/critical COVID-19 infection. MIS-C patients had a higher prevalence of fever, mucocutaneous, cardiac and gastrointestinal involvement and a lower prevalence of respiratory symptoms (P&lt;0.05). Significantly lower hemoglobin, platelet count, serum electrolytes, and significantly elevated inflammatory and coagulation markers were obser</pubmed_abstract><journal>Indian pediatrics</journal><pagination>120-124</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8913231</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Factors Differentiating Multisystem Inflammatory Syndrome in Children (MIS-C) From Severe/Critical COVID-19 Infection in Children.</pubmed_title><pmcid>PMC8913231</pmcid><pubmed_authors>Talathi S</pubmed_authors><pubmed_authors>Gupta N</pubmed_authors></additional><is_claimable>false</is_claimable><name>Factors Differentiating Multisystem Inflammatory Syndrome in Children (MIS-C) From Severe/Critical COVID-19 Infection in Children.</name><description>&lt;h4>Objective&lt;/h4>To differentiate severe/critical coronavirus disease 2019 (COVID-19) infection from multisystem inflammatory syndrome in children (MIS-C).&lt;h4>Methods&lt;/h4>Single-center chart review comparing characteristics of children with MIS-C and 'severe/critical' COVID-19 infection. Multivariate logistic regression was performed to create predictive models for predicting MIS-C.&lt;h4>Results&lt;/h4>Of 68 patients, 28 (41.2%) had MIS-C while 40 (58.8%) had severe/critical COVID-19 infection. MIS-C patients had a higher prevalence of fever, mucocutaneous, cardiac and gastrointestinal involvement and a lower prevalence of respiratory symptoms (P&lt;0.05). Significantly lower hemoglobin, platelet count, serum electrolytes, and significantly elevated inflammatory and coagulation markers were obser</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Feb</publication><modification>2025-04-22T07:46:12.573Z</modification><creation>2025-02-19T00:47:17.613Z</creation></dates><accession>S-EPMC8913231</accession><cross_references><pubmed>34553691</pubmed></cross_references></HashMap>